HIV Infection, Antiretroviral Therapy and Cardiovascular Risk
Author Information
Author(s): de Gaetano Donati Katleen, Cauda Roberto, Iacoviello Licia
Primary Institution: Catholic University Medical School
Hypothesis
How do traditional cardiovascular risk factors and HIV infection itself contribute to cardiovascular disease risk in HIV-infected individuals?
Conclusion
HIV-infected patients face an increased risk of cardiovascular disease due to a combination of traditional risk factors and the effects of antiretroviral therapy.
Supporting Evidence
- HIV-infected individuals have a higher prevalence of traditional cardiovascular risk factors like smoking and diabetes.
- Studies show that the risk of cardiovascular disease increases with age and the duration of antiretroviral therapy.
- Patients on protease inhibitors have shown increased cardiovascular risk compared to those on other antiretroviral therapies.
Takeaway
People with HIV can get heart disease just like anyone else, especially if they smoke or have other health problems. Doctors need to help them stay healthy.
Methodology
The study reviewed various aspects of cardiovascular risk in HIV-infected patients, including traditional risk factors and the effects of antiretroviral therapy.
Potential Biases
Potential biases include confounding factors related to traditional cardiovascular risk factors not being fully controlled.
Limitations
The study faced challenges such as lack of matched controls and small sample sizes in some studies.
Participant Demographics
The study included a diverse population of HIV-infected individuals, with a significant proportion being older adults.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website